369 related articles for article (PubMed ID: 17459021)
1. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
[TBL] [Abstract][Full Text] [Related]
2. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.
Jianfeng G; Weiming Z; Ning L; Fangnan L; Li T; Nan L; Jieshou L
J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697
[TBL] [Abstract][Full Text] [Related]
3. [Serum citrulline: a potential marker for intestinal epithelial mass and absorption capacity in short bowel syndrome patients].
Gong JF; Zhu WM; Li N; Liu FN; Tan L; Luo N; Li JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):333-7. PubMed ID: 17659456
[TBL] [Abstract][Full Text] [Related]
4. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.
Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA
Am J Gastroenterol; 2007 Dec; 102(12):2814-9. PubMed ID: 17764491
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
[TBL] [Abstract][Full Text] [Related]
6. Plasma citrulline is a marker of absorptive small bowel length in patients with transient enterostomy and acute intestinal failure.
Picot D; Garin L; Trivin F; Kossovsky MP; Darmaun D; Thibault R
Clin Nutr; 2010 Apr; 29(2):235-42. PubMed ID: 19744750
[TBL] [Abstract][Full Text] [Related]
7. Plasma citrulline concentration as a marker for disease activity in patients with Crohn's disease.
Elkhatib I; Buchman AL
J Clin Gastroenterol; 2012 Apr; 46(4):308-10. PubMed ID: 21897281
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
[TBL] [Abstract][Full Text] [Related]
10. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
[TBL] [Abstract][Full Text] [Related]
11. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome.
Santarpia L; Catanzano F; Ruoppolo M; Alfonsi L; Vitale DF; Pecce R; Pasanisi F; Contaldo F; Salvatore F
Ann Nutr Metab; 2008; 53(2):137-42. PubMed ID: 18997462
[TBL] [Abstract][Full Text] [Related]
12. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.
Crenn P; Messing B; Cynober L
Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672
[TBL] [Abstract][Full Text] [Related]
13. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
15. Increased intestinal permeability in patients with inflammatory bowel disease.
Welcker K; Martin A; Kölle P; Siebeck M; Gross M
Eur J Med Res; 2004 Oct; 9(10):456-60. PubMed ID: 15546811
[TBL] [Abstract][Full Text] [Related]
16. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
[TBL] [Abstract][Full Text] [Related]
17. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of C-reactive protein for predicting activity level of Crohn's disease.
Chamouard P; Richert Z; Meyer N; Rahmi G; Baumann R
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):882-7. PubMed ID: 16630759
[TBL] [Abstract][Full Text] [Related]
19. Citrulline and intestinal fatty acid-binding protein: longitudinal markers of postweaning small intestinal function in pigs?
Berkeveld M; Langendijk P; Verheijden JH; Taverne MA; van Nes A; van Haard P; Koets AP
J Anim Sci; 2008 Dec; 86(12):3440-9. PubMed ID: 18708596
[TBL] [Abstract][Full Text] [Related]
20. [Intestinal permeability in relatives of patients with Crohn's disease].
Kohout P; Koref P
Vnitr Lek; 2001 Jun; 47(6):371-4. PubMed ID: 11494882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]